# Medlink Georgia, Inc.

Health Center, GA
Page: https://astrelis.co/providers/health_center/111084  
This twin: https://astrelis.co/providers/health_center/111084.md  
CMS Certification Number (CCN): 111084  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2021)

- **Total patients (UDS) (FY2024):** 69,031. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2021):** -81.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 44. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 30.1%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2021):** $0.3M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2021):** -2.3%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### MedLink Georgia, Inc., GA

Match to this profile: matched by name (method: name and state).

- FY ending 2025-03-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-03-GSAFAC-0000371177
- FY ending 2024-03-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-03-GSAFAC-0000044131
- FY ending 2023-03-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-03-GSAFAC-0000005074

| Line | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 5,270,041 [derived, p.6] | 2,555,846 [derived, p.6] | 8,220,286 [derived, p.5] |
| patient receivables, net (Statement of financial position) | 5,329,806 [derived, p.6] | 4,338,305 [derived, p.6] | 3,036,494 [derived, p.5] |
| grants and other receivables (Statement of financial position) | 871,155 [derived, p.6] | 704,130 [derived, p.6] | 356,649 [derived, p.5] |
| other current assets (Statement of financial position) | 697,246 [derived, p.6] | 523,459 [derived, p.6] | 394,906 [derived, p.5] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 12,168,248 [extracted, p.6] | 8,121,740 [extracted, p.6] | 12,008,335 [extracted, p.5] |
| property and equipment, net (Statement of financial position) | 38,725,940 [derived, p.6] | 39,265,434 [derived, p.6] | 27,559,530 [derived, p.5] |
| other long-term assets (Statement of financial position) | 1,345,565 [derived, p.6] | 1,785,752 [derived, p.6] | 1,695,891 [derived, p.5] |
| TOTAL ASSETS (Statement of financial position) | 52,239,753 [extracted, p.6] | 49,172,926 [extracted, p.6] | 41,263,756 [extracted, p.5] |
| payables and accrued expenses (Statement of financial position) | 4,127,815 [derived, p.7] | 3,352,495 [derived, p.7] | 4,178,735 [derived, p.5] |
| deferred revenue (Statement of financial position) | 17,100 [derived, p.7] | 15,390 [derived, p.7] | 105,311 [derived, p.5] |
| current debt and leases (Statement of financial position) | 1,709,300 [derived, p.7] | 6,223,647 [derived, p.7] | 811,413 [derived, p.5] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 5,854,215 [extracted, p.7] | 9,591,532 [extracted, p.7] | 5,095,459 [extracted, p.5] |
| long-term debt and leases (Statement of financial position) | 19,339,267 [derived, p.7] | 15,532,205 [derived, p.7] | 12,181,830 [derived, p.5] |
| other long-term liabilities (Statement of financial position) | 39,594 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 25,233,076 [extracted, p.7] | 25,123,737 [extracted, p.7] | 17,277,289 [extracted, p.5] |
| net assets without donor restrictions (Statement of financial position) | 26,917,493 [derived, p.7] | 23,844,810 [derived, p.7] | 23,961,890 [derived, p.5] |
| net assets with donor restrictions (Statement of financial position) | 89,184 [derived, p.7] | 204,379 [derived, p.7] | 24,577 [derived, p.5] |
| TOTAL NET ASSETS (Statement of financial position) | 27,006,677 [extracted, p.7] | 24,049,189 [extracted, p.7] | 23,986,467 [extracted, p.5] |
| patient service revenue, net (Statement of activities) | 52,138,052 [derived, p.8] | 46,096,332 [derived, p.8] | 36,301,839 [derived, p.6] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | 11,844,446 [derived, p.6] |
| other grants and contracts (Statement of activities) | 11,251,469 [derived, p.8] | 10,096,497 [derived, p.8] | 5,279,287 [derived, p.6] |
| contributions (Statement of activities) | 398,440 [derived, p.8] | 155,680 [derived, p.8] | 117,999 [derived, p.6] |
| other revenue (Statement of activities) | 2,360,184 [derived, p.8] | 1,749,782 [derived, p.8] | absent (not printed, or not read) |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 66,148,145 [extracted, p.8] | 58,098,291 [extracted, p.8] | 53,543,571 [extracted, p.6] |
| salaries and benefits (Statement of activities) | 37,577,839 [derived, p.8] | 36,182,996 [derived, p.8] | absent (not printed, or not read) |
| supplies and pharmaceuticals (Statement of activities) | 18,492,477 [derived, p.8] | 16,304,923 [derived, p.8] | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | 3,541,538 [derived, p.8] | 3,146,787 [derived, p.8] | absent (not printed, or not read) |
| occupancy (Statement of activities) | 569,256 [derived, p.8] | 641,245 [derived, p.8] | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | 2,189,152 [derived, p.8] | 1,697,445 [derived, p.8] | absent (not printed, or not read) |
| interest (Statement of activities) | 1,066,352 [derived, p.8] | 864,621 [derived, p.8] | absent (not printed, or not read) |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 63,436,614 [extracted, p.8] | 58,838,017 [extracted, p.8] | 48,674,230 [extracted, p.6] |
| OPERATING RESULT (Statement of activities) | 2,711,531 [extracted, p.8] | -739,726 [extracted, p.8] | 4,869,341 [extracted, p.6] |
| non-operating and other changes (Statement of activities) | 245,957 [derived] | 802,448 [derived] | 131,415 [derived, p.6] |
| CHANGE IN NET ASSETS (Statement of activities) | 2,957,488 [extracted, p.9] | 62,722 [extracted, p.9] | 5,000,756 [extracted, p.6] |
| net assets, beginning (Statement of activities) | 24,049,189 [extracted, p.9] | 23,986,467 [extracted, p.9] | 18,985,711 [extracted, p.6] |
| net assets, end (Statement of activities) | 27,006,677 [extracted, p.9] | 24,049,189 [extracted, p.9] | 23,986,467 [extracted, p.6] |

| Ratio | FY ending 2025-03-31 | FY ending 2024-03-31 | FY ending 2023-03-31 |
|---|---:|---:|---:|
| Days cash on hand | 31 days [plausible] | 16 days [plausible] | absent [not computed] |
| Current ratio | 2.08x [plausible] | 0.85x [plausible] | 2.36x [plausible] |
| Operating margin | 4.1% [plausible] | -1.3% [plausible] | 9.1% [plausible] |
| Total margin | 4.5% [plausible] | 0.1% [plausible] | 9.3% [plausible] |
| Patient revenue share | 78.8% [plausible] | 79.3% [plausible] | 67.8% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | 32.0% [plausible] |
| Salaries share | 59.2% [plausible] | 61.5% [plausible] | absent [not computed] |
| Days in patient receivables | 37 days [plausible] | 34 days [plausible] | 31 days [plausible] |
| Debt to net assets | 0.78x [plausible] | 0.90x [plausible] | 0.54x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Probable). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (MedLink Georgia, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Medlink Georgia, Inc.", https://astrelis.co/providers/health_center/111084, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.